Sparrow Acoustics

Company profile

About Sparrow Acoustics

Sparrow BioAcoustics is a Canadian medical technology company specializing in cardiac and pulmonary bioacoustic analysis. The company's flagship product, Stethophone Pro, is a regulated Software as a Medical Device platform that transforms smartphones into professional-grade cardiac assessment tools capable of detecting valvular heart disease, arrhythmias, and structural heart conditions. The platform employs proprietary AI phonoscopy technology trained on millions of heart cycles to analyze cardiac sounds and generate structured clinical signals. Stethophone Pro is designed for upstream detection in routine clinical workflows including primary care, urgent care, pre-operative assessments, and hospital intake. The system performs deep heart sound characterization through advanced signal processing, temporal alignment, and clinical interpretation to identify murmurs and other cardiac abnormalities. Stethophone Pro is FDA-cleared and regulated as a medical device in the USA, Canada, and Ukraine. The platform integrates into existing clinical smartphone programs without requiring specialized hardware, enabling scalable cardiovascular detection infrastructure across health systems. Clinical validation studies demonstrate sensitivity and specificity exceeding 93% for murmur detection and 97% accuracy for cardiac cycle analysis. The company serves health systems, cardiology programs, and structural heart teams seeking to improve upstream patient identification, referral precision, and care pathway efficiency.

Company description · Sparrow Acoustics official website